Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Treatment of Patients With Blepharitis and Facial Rosacea

ClinicalTrials.gov ID: NCT00560703

Public ClinicalTrials.gov record NCT00560703. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea

Study identification

NCT ID
NCT00560703
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Galderma R&D
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

  • COL-101 (doxycycline, USP) capsules Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Apr 30, 2009
Completion
Jun 30, 2009
Last update posted
Feb 17, 2021

2007 – 2009

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Pleasant Valley Ophthalmology Little Rock Arkansas 72212
Warren Scherer, MD Naples Florida 34103
Kentucky Lions Eye Center Louisville Kentucky 40202
Washington University School of Medicine St Louis Missouri 63110
Marguerite McDonald, MD Lynbrook New York 11563
Dean McGee Eye Institute Oklahoma City Oklahoma 73104
Anita Nevyas-Wallace, MD Bala-Cynwyd Pennsylvania 19004
Tanner Clinic Layton Utah 84041

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00560703, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00560703 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →